| Dr Muhammad Raza, MD | |
|
9200 N Central Ave Ste 2, Phoenix, AZ 85020-2463 | |
| (480) 999-4954 | |
| (480) 999-4712 |
| Full Name | Dr Muhammad Raza |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 34 Years |
| Location | 9200 N Central Ave Ste 2, Phoenix, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669422119 | NPI | - | NPPES |
| 577497 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 29478 (Arizona) | Secondary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | 29478 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St. Joseph's Hospital And Medical Center | Phoenix, AZ | Hospital |
| Abrazo Central Campus | Phoenix, AZ | Hospital |
| Summit Healthcare Regional Medical Center | Show low, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alveo Lc | 1254573546 | 3 |
| Arizona Acute Medical Services 1 Pc | 6204113970 | 44 |
| Unomed Llc | 7416261086 | 8 |
News Archive
The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that SAB-185, a novel polyclonal antibody therapy, has demonstrated safety and efficacy in phase 2 that meet the criteria for graduation to phase 3 in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial (ACTG A5401).
The drug retigabine was approved in March 2011 as add-on therapy for adults with epileptic seizures. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether retigabine offers an added benefit compared with the present standard therapy.
An international research team has identified a number of unsuspected genetic variants associated with systolic blood pressure (SBP), diastolic blood pressure (DBP), and hypertension (high blood pressure), suggesting potential avenues of investigation for the prevention or treatment of hypertension.
The University of Illinois at Chicago College of Medicine has received a $1.92 million grant from the U.S. Department of Health and Human Services to expand its family medicine residency program.
"Scientists from 15 countries are calling for a better political response to the provision of water and energy to meet the challenge of feeding a world of nine billion people within 30 years," Reuters reports.
› Verified 7 days ago
| Entity Name | Arizona Pulmonary Specialists Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215986468 PECOS PAC ID: 7618863192 Enrollment ID: O20040223000693 |
News Archive
The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that SAB-185, a novel polyclonal antibody therapy, has demonstrated safety and efficacy in phase 2 that meet the criteria for graduation to phase 3 in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial (ACTG A5401).
The drug retigabine was approved in March 2011 as add-on therapy for adults with epileptic seizures. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether retigabine offers an added benefit compared with the present standard therapy.
An international research team has identified a number of unsuspected genetic variants associated with systolic blood pressure (SBP), diastolic blood pressure (DBP), and hypertension (high blood pressure), suggesting potential avenues of investigation for the prevention or treatment of hypertension.
The University of Illinois at Chicago College of Medicine has received a $1.92 million grant from the U.S. Department of Health and Human Services to expand its family medicine residency program.
"Scientists from 15 countries are calling for a better political response to the provision of water and energy to meet the challenge of feeding a world of nine billion people within 30 years," Reuters reports.
› Verified 7 days ago
| Entity Name | Alveo Lc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639517436 PECOS PAC ID: 1254573546 Enrollment ID: O20130816000077 |
News Archive
The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that SAB-185, a novel polyclonal antibody therapy, has demonstrated safety and efficacy in phase 2 that meet the criteria for graduation to phase 3 in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial (ACTG A5401).
The drug retigabine was approved in March 2011 as add-on therapy for adults with epileptic seizures. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether retigabine offers an added benefit compared with the present standard therapy.
An international research team has identified a number of unsuspected genetic variants associated with systolic blood pressure (SBP), diastolic blood pressure (DBP), and hypertension (high blood pressure), suggesting potential avenues of investigation for the prevention or treatment of hypertension.
The University of Illinois at Chicago College of Medicine has received a $1.92 million grant from the U.S. Department of Health and Human Services to expand its family medicine residency program.
"Scientists from 15 countries are calling for a better political response to the provision of water and energy to meet the challenge of feeding a world of nine billion people within 30 years," Reuters reports.
› Verified 7 days ago
| Entity Name | Unomed Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972912228 PECOS PAC ID: 7416261086 Enrollment ID: O20150728003597 |
News Archive
The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that SAB-185, a novel polyclonal antibody therapy, has demonstrated safety and efficacy in phase 2 that meet the criteria for graduation to phase 3 in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial (ACTG A5401).
The drug retigabine was approved in March 2011 as add-on therapy for adults with epileptic seizures. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether retigabine offers an added benefit compared with the present standard therapy.
An international research team has identified a number of unsuspected genetic variants associated with systolic blood pressure (SBP), diastolic blood pressure (DBP), and hypertension (high blood pressure), suggesting potential avenues of investigation for the prevention or treatment of hypertension.
The University of Illinois at Chicago College of Medicine has received a $1.92 million grant from the U.S. Department of Health and Human Services to expand its family medicine residency program.
"Scientists from 15 countries are calling for a better political response to the provision of water and energy to meet the challenge of feeding a world of nine billion people within 30 years," Reuters reports.
› Verified 7 days ago
| Entity Name | Arizona Acute Medical Services 1 Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154860674 PECOS PAC ID: 6204113970 Enrollment ID: O20170505001284 |
News Archive
The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that SAB-185, a novel polyclonal antibody therapy, has demonstrated safety and efficacy in phase 2 that meet the criteria for graduation to phase 3 in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial (ACTG A5401).
The drug retigabine was approved in March 2011 as add-on therapy for adults with epileptic seizures. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether retigabine offers an added benefit compared with the present standard therapy.
An international research team has identified a number of unsuspected genetic variants associated with systolic blood pressure (SBP), diastolic blood pressure (DBP), and hypertension (high blood pressure), suggesting potential avenues of investigation for the prevention or treatment of hypertension.
The University of Illinois at Chicago College of Medicine has received a $1.92 million grant from the U.S. Department of Health and Human Services to expand its family medicine residency program.
"Scientists from 15 countries are calling for a better political response to the provision of water and energy to meet the challenge of feeding a world of nine billion people within 30 years," Reuters reports.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Muhammad Raza, MD 9200 N Central Ave Ste 2, Phoenix, AZ 85020-2463 Ph: (480) 999-4954 | Dr Muhammad Raza, MD 9200 N Central Ave Ste 2, Phoenix, AZ 85020-2463 Ph: (480) 999-4954 |
News Archive
The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that SAB-185, a novel polyclonal antibody therapy, has demonstrated safety and efficacy in phase 2 that meet the criteria for graduation to phase 3 in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial (ACTG A5401).
The drug retigabine was approved in March 2011 as add-on therapy for adults with epileptic seizures. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether retigabine offers an added benefit compared with the present standard therapy.
An international research team has identified a number of unsuspected genetic variants associated with systolic blood pressure (SBP), diastolic blood pressure (DBP), and hypertension (high blood pressure), suggesting potential avenues of investigation for the prevention or treatment of hypertension.
The University of Illinois at Chicago College of Medicine has received a $1.92 million grant from the U.S. Department of Health and Human Services to expand its family medicine residency program.
"Scientists from 15 countries are calling for a better political response to the provision of water and energy to meet the challenge of feeding a world of nine billion people within 30 years," Reuters reports.
› Verified 7 days ago
Moustafa I Hazin, D.O. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 W Thomas Rd, Suite 900, Phoenix, AZ 85013 Phone: 602-406-5590 Fax: 602-406-7165 | |
Dr. Ali Shaheen Al-yaqoobi, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 2601 E Roosevelt St, Phoenix, AZ 85008 Phone: 602-344-5411 | |
Dana Archbold, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 E Mcdowell Rd, Phoenix, AZ 85006 Phone: 602-839-2296 Fax: 602-839-2084 | |
Catalina Nicole Flores, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 350 W Thomas Rd Dept Of, Phoenix, AZ 85013 Phone: 602-406-3000 | |
Kristina Yancey, Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 5777 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-342-2000 | |
Dr. Francisco Cordova, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 29 W Edgemont Ave, Phoenix, AZ 85003 Phone: 602-263-8971 Fax: 602-263-8971 | |
Dr. Dimpy Kapoor, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 9305 W Thomas Rd, Ste 455, Phoenix, AZ 85037 Phone: 623-399-9010 Fax: 623-399-9013 |